IL1B and rheumatoid arthritis: In this study, we also found that the prepared compounds inhibit the production of IL-1β, since activated macrophages are the key effector cells in RA pathogenesis, and these activated macrophages secrete proinflammatory cytokines such as IL-6 and IL-1β and give rise to localized and systemic inflammation [30].